Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies
Abstract. Epidermal growth factor receptor (EGFR) mutations are common oncogenic driver mutations in patients with non-small cell lung cancer (NSCLC). The application of EGFR-tyrosine kinase inhibitors (TKIs) is beneficial for patients with advanced and early-stage NSCLC. With the development of nex...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer
2023-12-01
|
| coleção: | Chinese Medical Journal |
| Acesso em linha: | http://journals.lww.com/10.1097/CM9.0000000000002548 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|